Article

Risk factors for retinal detachment after clear lens replacement outlined

Washington, DC &#8212 Clear lens replacement is considered a good option for patients who are well-educated about the risk factors pertaining to retinal detachment, explained J. Pitzer Gills III, MD, who spoke during a cataract/refractive symposium on refractive lens exchange, bioptics, and intracorneal lenses during the American Society of Cataract and Refractive Surgery annual meeting.

April 18 - Washington, DC - Clear lens replacement is considered a good option for patients who are well-educated about the risk factors pertaining to retinal detachment, explained J. Pitzer Gills III, MD, who spoke during a cataract/refractive symposium on refractive lens exchange, bioptics, and intracorneal lenses during the American Society of Cataract and Refractive Surgery annual meeting.

In an ongoing study of 890 eyes that underwent clear lens exchange and were followed from 1997 to the present, Dr. Gills reported that eight retinal detachments had occurred out of 438 eyes with myopia and none had been seen in the 452 hyperopic cases. Only 6 patients had retinal detachments because four of the detachments occurred in 2 patients. Most of the wounds were small, clear corneal incisions, except for the cases where PMMA lenses were implanted.

In this study, the YAG capsulotomy rate was 40% and 4 of the 8 eyes with retinal detachments had undergone the YAG procedure prior to the retinal detachments, he noted.

Patients who had retinal detachments had axial lengths of about 26 mm although one would expect those with longer axial lengths to be at higher risk. The axial lengths in this study ranged from below 20 mm up to 33 mm, Dr. Gills noted.

Also, patients who have had a retinal detachment after clear lens replacement in one eye should be followed closely in the fellow eye because they are at risk for this complication again, he said.

"The retina should be carefully evaluated preoperatively and treated prior to clear lens replacement if the lattice looks suspicious," Dr. Gills stressed. "We are a little more aggressive now in pretreating any retinal lesions, even some holes that donít look suspicious. The patient may be predisposed to the risk."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
(Image credit: Ophthalmology Times) Neda Shamie_Controversies in Modern Eye Care 2025
(Image credit: Ophthalmology Times) The synergy of cornea, cataract, and refractive surgery through the decades: insights from George O. Waring IV, MD
(Image credit: Ophthalmology Times) AGS 2025: A look at Gemini and the MIGS revolution with Mona Kaleem, MD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
© 2025 MJH Life Sciences

All rights reserved.